Company
HAYA Therapeutics
- Biotech
- Founded:
- 2019
- Location:
- Epalinges, Switzerland
Description
HAYA Therapeutics develops RNA-guided medicines that use functional genomics and computational tools to identify, target, and monitor non-coding RNAs driving disease cell states for restoring cellular health.
HAYA Therapeutics is located in the Lake Geneva ecosystem.
Related
deCODE geneticsdeCODE genetics operates a human gene-discovery engine that analyzes population-scale genomic data to identify genetic risk factors and…
Hedera DxHedera Dx enables hospital laboratories to perform in-house NGS genomic profiling, offering FFPE, ctDNA (liquid biopsy) and RNA-only…
DebiopharmDebiopharm develops and manufactures pharmaceutical drugs and invests in digital health, focusing on oncology and bacterial infections and…
NanoPhoriaNanoPhoria develops an inhaled Nano-in-Micro delivery platform and formulations to deliver therapeutic peptides and RNAs for…
Molecular PartnersMolecular Partners develops DARPin therapeutics, including Radio-DARPins and logic-gated Switch-DARPins, to target DLL3, FAP x CD40, and…
SNIPR BIOMESNIPR BIOME develops CRISPR-based medicines that use bacteriophages, engineered probiotics, and CRISPR systems to target…
OphiomicsOphiomics develops diagnostic products combining artificial intelligence and genomics for precision liver medicine, helping clinicians…
OncolinesOncolines provides precision medicine services in oncology and cancer immunotherapy, offering cell‑based assays, profiling platforms,…
ResQ BiotechResQ Biotech builds a living-cell discovery platform that biosynthesizes and functionally screens ultra-large libraries to identify…